| Literature DB >> 31508330 |
Mohammad Reza Asgharzadeh1,2,3, Mohammad M Pourseif1, Jaleh Barar1,4, Morteza Eskandani1, Mojtaba Jafari Niya2,3, Mohammad Reza Mashayekhi5, Yadollah Omidi1,4.
Abstract
Introduction: Testis-specific gene antigen 10 (TSGA10) is a less-known gene, which is involved in the vague biological paths of different cancers. Here, we investigated the TSGA10 expression using different concentrations of glucose under hypoxia and also its interaction with the hypoxia-inducible factor 1 (HIF-1).Entities:
Keywords: Breast cancer; HIF-1α; Hypoxia; Molecular docking; Protein-protein interaction network; TSGA10
Year: 2019 PMID: 31508330 PMCID: PMC6726749 DOI: 10.15171/bi.2019.19
Source DB: PubMed Journal: Bioimpacts ISSN: 2228-5652
Fig. 1
Fig. 2
Fig. 3The modeling validation assays using different online web-servers
|
|
|
|
|
| ProSA-web | Modeling verification by calculating an overall quality Z-score | - 3.45 | NPS* |
| ERRAT (%) | The overall quality for non-bounded atomic interactions | 91.65 | >50% |
| VERIFY3D (%) | The number of residues having an average 3D/1D score above 2.0 | 72.00 | >80% |
| RAMPAGE (%) | The residues within the allowed region in psi/phi Ramachandran plot | 98.60 | >90% |
* Native protein size (NPS): This criterion checks the z-score of the target structure whether is within the range of scores typically identified for the native proteins of similar size.
Fig. 4
Fig. 5
Fig. 6The topological parameters of the constructed PPI network
|
|
|
| Number of nodes | 57 |
| Network density | 0.242 |
| Network heterogeneity | 0.636 |
| Isolated nodes | 0 |
| Number of self-loops | 0 |
| Multi-edge node pairs | 0 |
| Clustering coefficient | 0.635 |
| Connected components | 1 |
| Network diameter | 4 |
| Network radius | 2 |
| Network centralization | 0.470 |
| Shortest paths | 3192 |
| Average number of neighbors | 13.579 |
| Characteristic path length | 2.053 |
The list of top 10 hubs obtained by employing the nine different types of scoring algorithms of CytoHubba plugin
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
| ||
| 1 | HIF-1α | HIF1- α | HIF-1α | HIF-1α | TSGA10 | VEGFA | HSP90AA1 | HIF-1α | HIF-1α | HIF-1α |
| 2 | HSP90AA1 | VEGFA | VEGFA | VEGFA | TEKT3 | HIF-1α | HIF-1α | VEGFA | VEGFA | VEGFA |
| 3 | TSGA10 | ARNT | HSP90AA1 | ARNT | LOC81691 | TP53 | AKT1 | ARNT | ARNT | HSP90AA1 |
| 4 | AKT1 | AKT1 | TSGA10 | HSP90AA1 | SPAG6 | AKT1 | VEGFA | HSP90AA1 | HSP90AA1 | AKT1 |
| 5 | ARNT | HSP90AA1 | APP | AKT1 | TUBA3C | JUN | ARNT | AKT1 | AKT1 | ARNT |
| 6 | VEGFA | TP53 | TP53 | TP53 | BACE1 | EP300 | TSGA10 | TP53 | TP53 | TP53 |
| 7 | TUPA3C | VHL | SPAG6 | JUN | HIF-1α | EGFR | APP | VHL | VHL | TSGA10 |
| 8 | SPAG6 | JUN | TUBB4B | EGFR | CXCR4 | CDKN1A | VHL | JUN | JUN | VHL |
| 9 | APP | EGFR | AKT1 | VHL | ADM | MDM2 | NOTCH1 | EGFR | EGFR | JUN |
| 10 | VHL | EPO | FLT1 | EP300 | BHLHE41 | HSP90AA1 | TP53 | EP300 | EPO | EGFR |
MNC: maximum neighborhood component; MCC: maximal clique centrality.
a The final consensus protein hubs are ranked as 1 (as the highest) to 10 (the lowest).
Fig. 7
Fig. 8List of functional clusters with a co-occurrence meaning the biological pathways common between the THCNs
|
| ||||
|
| ||||
|
|
|
|
|
|
| KEGG_PATHWAY | Renal cell carcinoma | 3.45E-09 | 6 |
|
| BIOCARTA | Hypoxia-Inducible Factor in the cardiovascular system | 3.62E-09 | 6 |
|
| KEGG_PATHWAY | HIF-1α signaling pathway | 2.80E-08 | 6 |
|
| GOTERM_BP_DIRECT | Regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418) | 3.46E-07 | 4 |
|
| GOTERM_BP_DIRECT | Positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 3.05E-05 | 3 |
|
| BIOCARTA | VEGF, Hypoxia, and Angiogenesis | 3.30E-04 | 4 |
|
| GOTERM_BP_DIRECT | Response to hypoxia (GO:0001666) | 0.004 | 3 |
|
|
| ||||
|
| ||||
|
|
|
|
|
|
| GOTERM_BP_DIRECT | Positive regulation of endothelial cell proliferation (GO:0001938) | 3.24E-08 | 5 |
|
| GOTERM_BP_DIRECT | Outflow tract morphogenesis (GO:0003151) | 0.0003 | 3 |
|
| GOTERM_BP_DIRECT | Angiogenesis (GO:0001525) | 0.006 | 3 |
|
|
| ||||
|
| ||||
|
|
|
|
|
|
| KEGG_PATHWAY | Pathways in cancer (hsa05200) | 1.02E-10 | 9 |
|
| GOTERM_MF_DIRECT | Enzyme binding (GO:0019899) | 3.42E-07 | 6 |
|
| UP_KEYWORDS | Ubl conjugation | 3.68E-04 | 6 |
|
| GOTERM_CC_DIRECT | Nucleoplasm (GO:0005654) | 6.99E-04 | 7 |
|
| UP_KEYWORDS | Nucleus | 0.0016 | 8 |
|
| GOTERM_CC_DIRECT | Nucleus (GO:0005634) | 0.004 | 8 |
|
| UP_KEYWORDS | Acetylation | 0.009 | 6 |
|
| GOTERM_CC_DIRECT | Cytosol (GO:0005829) | 0.013 | 6 |
|
| UP_KEYWORDS | Phosphoprotein | 0.025 | 8 |
|
BP: biological process; MF: molecular function; CC: cellular component. GO: Gene ontology.
Fig. 9
Fig. 10